CORT vs WST · P/E 199, rev $421.1M vs P/E 35, rev $1.72B
Corcept Therapeutics Incorporated (CORT) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Corcept Therapeutics Incorporated (CORT) is a biotechnology company listed on US.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported CORT revenue for 2026-06-30 was $421.1M. Net income was $11.2M. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
CORT currently screens at market cap $7.46B and trailing P/E 198.5. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the CORT and WST stock pages for the full models.
Not investment advice.